A.B. Abbott

742 total citations
14 papers, 649 citations indexed

About

A.B. Abbott is a scholar working on Infectious Diseases, Molecular Biology and Physiology. According to data from OpenAlex, A.B. Abbott has authored 14 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 3 papers in Molecular Biology and 3 papers in Physiology. Recurrent topics in A.B. Abbott's work include Antifungal resistance and susceptibility (8 papers), Adenosine and Purinergic Signaling (3 papers) and Plant Pathogens and Fungal Diseases (3 papers). A.B. Abbott is often cited by papers focused on Antifungal resistance and susceptibility (8 papers), Adenosine and Purinergic Signaling (3 papers) and Plant Pathogens and Fungal Diseases (3 papers). A.B. Abbott collaborates with scholars based in United Kingdom and United States. A.B. Abbott's co-authors include Frank C. Odds, Cecelia Webster, Alan Cockayne, Robert L. Stiller, H.J. Scholer, Annemarie Polak, David A. Stevens, Peter F. Troke, Michael F. Toney and Daniel R. Gamelin and has published in prestigious journals such as Chemistry of Materials, Journal of Clinical Microbiology and Journal of Antimicrobial Chemotherapy.

In The Last Decade

A.B. Abbott

14 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.B. Abbott United Kingdom 11 451 307 107 87 80 14 649
A Viudes Spain 14 647 1.4× 448 1.5× 88 0.8× 117 1.3× 73 0.9× 32 799
J Rhine-Chalberg United States 7 725 1.6× 558 1.8× 69 0.6× 95 1.1× 83 1.0× 8 843
R Guinet France 14 409 0.9× 302 1.0× 110 1.0× 222 2.6× 143 1.8× 62 749
H.J. Scholer Switzerland 14 585 1.3× 483 1.6× 73 0.7× 112 1.3× 73 0.9× 42 869
Luigi Falconi Di Francesco Italy 13 509 1.1× 421 1.4× 46 0.4× 59 0.7× 48 0.6× 15 588
Eveline Pı́polo Milan Brazil 18 480 1.1× 445 1.4× 113 1.1× 97 1.1× 110 1.4× 49 809
Margarete Borg‐von Zepelin Germany 15 546 1.2× 419 1.4× 71 0.7× 132 1.5× 25 0.3× 20 780
Laurence F. Mirels United States 10 539 1.2× 456 1.5× 42 0.4× 131 1.5× 45 0.6× 11 734
Smita Sarma India 9 648 1.4× 577 1.9× 54 0.5× 57 0.7× 95 1.2× 22 790
Yoshimura Fukazawa Japan 14 318 0.7× 275 0.9× 83 0.8× 229 2.6× 67 0.8× 52 658

Countries citing papers authored by A.B. Abbott

Since Specialization
Citations

This map shows the geographic impact of A.B. Abbott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.B. Abbott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.B. Abbott more than expected).

Fields of papers citing papers by A.B. Abbott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.B. Abbott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.B. Abbott. The network helps show where A.B. Abbott may publish in the future.

Co-authorship network of co-authors of A.B. Abbott

This figure shows the co-authorship network connecting the top 25 collaborators of A.B. Abbott. A scholar is included among the top collaborators of A.B. Abbott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.B. Abbott. A.B. Abbott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Abbott, A.B., et al.. (2024). Leveraging Cation Exchange in InP Magic-Sized Clusters To Access Coinage Metal Phosphide Nanocrystals. Chemistry of Materials. 36(6). 2888–2897. 6 indexed citations
2.
Abbott, A.B. & Frank C. Odds. (1989). Abrogation by glucose of the ATP suppression induced by miconazole in Candida albicans. Journal of Antimicrobial Chemotherapy. 24(6). 905–919. 4 indexed citations
3.
4.
Odds, Frank C., et al.. (1986). Antifungal effects of fluconazole (UK 49858), a new triazole antifungal, in vitro. Journal of Antimicrobial Chemotherapy. 18(4). 473–478. 70 indexed citations
5.
Odds, Frank C., et al.. (1985). Suppression of ATP inCandida albicansby imidazole and derivative antifungal agents. Medical Mycology. 23(6). 415–424. 10 indexed citations
6.
Odds, Frank C., et al.. (1985). Suppression of ATP in Candida albicans by imidazole and derivative antifungal agents.. PubMed. 23(6). 415–24. 10 indexed citations
7.
8.
9.
Odds, Frank C. & A.B. Abbott. (1984). Relative inhibition factors—a novel approach to the assessment of antifunga antibiotics in vitro. Journal of Antimicrobial Chemotherapy. 13(1). 31–43. 30 indexed citations
10.
Odds, Frank C. & A.B. Abbott. (1983). Modification and extension of tests for differentiation ofCandidaspecies and strains. Medical Mycology. 21(1). 79–81. 76 indexed citations
11.
Odds, Frank C., A.B. Abbott, Robert L. Stiller, et al.. (1983). Analysis of Candida albicans phenotypes from different geographical and anatomical sources. Journal of Clinical Microbiology. 18(4). 849–857. 58 indexed citations
12.
Odds, Frank C., et al.. (1983). Candida albicans strain types from the genitalia of patients with and without Candida infection. European Journal of Obstetrics & Gynecology and Reproductive Biology. 15(1). 37–43. 31 indexed citations
13.
Odds, Frank C. & A.B. Abbott. (1980). A simple system for the presumptive identification ofCandida albicansand differentiation of strains within the species. Medical Mycology. 18(4). 301–317. 163 indexed citations
14.
Odds, Frank C., et al.. (1978). Peptones and mycological reproducibility. Medical Mycology. 16(4). 237–246. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A Viudes Breakdown of academic impact, for papers by J Rhine-Chalberg Breakdown of academic impact, for papers by R Guinet Breakdown of academic impact, for papers by H.J. Scholer Breakdown of academic impact, for papers by Luigi Falconi Di Francesco Breakdown of academic impact, for papers by Eveline Pı́polo Milan Breakdown of academic impact, for papers by Margarete Borg‐von Zepelin Breakdown of academic impact, for papers by Laurence F. Mirels Breakdown of academic impact, for papers by Smita Sarma Breakdown of academic impact, for papers by Yoshimura Fukazawa
Rankless by CCL
2026